Loading...
XSHG
603976
Market cap621mUSD
Jul 09, Last price  
27.69CNY
1D
1.88%
1Q
37.90%
IPO
70.93%
Name

CHONGQING ZHENGCHUAN PHARMAC PCKG CO LTD

Chart & Performance

D1W1MN
XSHG:603976 chart
P/E
223.04
P/S
6.38
EPS
0.12
Div Yield, %
0.89%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
5.65%
Revenues
661m
-17.53%
405,801,648436,034,294479,683,553469,994,516508,681,598595,781,309521,080,826501,981,690796,657,257796,198,291900,648,636801,121,623660,690,589
Net income
19m
-64.50%
54,738,85468,913,13960,698,98570,511,33282,178,38982,766,63361,056,67053,050,478106,603,63764,770,60040,267,66053,248,78918,903,769
CFO
140m
+24.36%
42,036,59076,862,58914,204,22125,717,77552,499,86064,296,75055,273,077121,794,840104,966,81938,426,207194,196,180112,180,461139,503,316
Dividend
May 21, 20250.246 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. specializes in the research, development, manufacturing, and sale of various glass packaging solutions for the pharmaceutical industry across China. Their extensive product line includes medium borosilicate glass ampoule and injection bottles, low borosilicate tubular vials and ampoules, oral liquid vials, and screw-neck vials. The company also provides plastic flip-off and aluminum caps, as well as borosilicate and soda-lime glass control bottles. Established in 1988, the firm's headquarters are situated in Chongqing, China.
IPO date
Aug 22, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT